Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 3. Biomarkers of biological effect

被引:16
作者
Ogden, Michael W. [1 ]
Marano, Kristin M. [1 ]
Jones, Bobbette A. [2 ]
Morgan, Walter T. [2 ]
Stiles, Mitchell F. [2 ]
机构
[1] RAI Serv Co, Winston Salem, NC 27102 USA
[2] RJ Reynolds Tobacco Co, Winston Salem, NC USA
关键词
Inflammation; multi-center randomized study; oxidative stress; risk continuum; CARDIOVASCULAR-DISEASE BIOMARKERS; SMOKELESS TOBACCO; POTENTIAL HARM; UNITED-STATES; SMOKING; SMOKERS; PRODUCTS; RISK; REDUCTION; MORTALITY;
D O I
10.3109/1354750X.2015.1094135
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A randomized, multi-center study of adult cigarette smokers switched to tobacco-heating cigarettes, snus or ultra-low machine yield tobacco-burning cigarettes (50/group) for 24 weeks was conducted. Evaluation of biomarkers of biological effect (e.g. inflammation, lipids, hypercoaguable state) indicated that the majority of consistent and statistically significant improvements over time within each group were observed in markers of inflammation. Consistent and statistically significant differences in pairwise comparisons between product groups were not observed. These findings are relevant to the understanding of biomarkers of biological effect related to cigarette smoking as well as the risk continuum across various tobacco products (ClinicalTrials.gov Identifier: NCT02061917).
引用
收藏
页码:404 / 410
页数:7
相关论文
共 33 条
[11]  
International Conference on Harmonization (ICH), 1996, GUID IND E6 GOOD CHE
[12]   Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers [J].
Kondo, T ;
Hayashi, M ;
Takeshita, K ;
Numaguchi, Y ;
Kobayashi, K ;
Iino, S ;
Inden, Y ;
Murohara, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) :1442-1447
[14]   Summary of the epidemiological evidence relating snus to health [J].
Lee, Peter N. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2011, 59 (02) :197-214
[15]  
Levy DT, 2004, CANCER EPIDEM BIOMAR, V13, P2035
[16]   Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective [J].
Lowe, Frazer J. ;
Luettich, Karsta ;
Gregg, Evan O. .
BIOMARKERS, 2013, 18 (03) :183-195
[17]   Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers [J].
Lowe, Frazer J. ;
Gregg, Evan O. ;
McEwan, Michael .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (03) :311-320
[18]   Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey [J].
Marano, Kristin M. ;
Kathman, Steven J. ;
Jones, Bobbette A. ;
Nordskog, Brian K. ;
Brown, Buddy G. ;
Borgerding, Michael F. .
INHALATION TOXICOLOGY, 2015, 27 (03) :167-173
[19]   Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect [J].
Nordskog, Brian K. ;
Brown, Buddy G. ;
Marano, Kristin M. ;
Campell, Leanne R. ;
Jones, Bobbette A. ;
Borgerding, Michael F. .
INHALATION TOXICOLOGY, 2015, 27 (03) :157-166
[20]   Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach [J].
Nutt, David J. ;
Phillips, Lawrence D. ;
Balfour, David ;
Curran, H. Valerie ;
Dockrell, Martin ;
Foulds, Jonathan ;
Fagerstrom, Karl ;
Letlape, Kgosi ;
Milton, Anders ;
Polosa, Riccardo ;
Ramsey, John ;
Sweanor, David .
EUROPEAN ADDICTION RESEARCH, 2014, 20 (05) :218-225